Leslie Massey
Multiple sclerosis (MS) is a chronic disease that affects the central nervous system, including the brain, spinal cord, and optic nerve. It is the most common neurological cause of disability among young adults in Australia. The number of Australians living with MS has been increasing over time, with over 33,000 people affected as of 2021. This rise in prevalence has implications for the availability of resources and treatments for those living with the disease. While there is currently no cure for MS, advancements in therapeutic and technological treatments are helping people manage their symptoms and improve their quality of life.
| Characteristics | Values |
|---|---|
| Total number of people with MS in Australia | Over 30,000 (2021 figure: 33,335) |
| Number of people with MS in Queensland | 5,535 |
| Average number of new diagnoses per week | Over 10 |
| Prevalence per 100,000 Australians | 2021: 131.12; 2017: 103.7 |
| Total costs for people with MS in Australia | 2021: $2.5 billion; 2017: $1.75 billion |
| Most common form of MS | Relapsing remitting MS |
| Most common age of diagnosis | 30 |
| Gender ratio | 3 out of 4 Australians with MS are women |
| MS prevalence by ancestry | Highest in people of northern European ancestry |
| MS prevalence by region | Higher in southern states than northern regions |
| MS prevalence by state | Highest increase in Tasmania |
| Lifestyle risk factors | Adolescent obesity, insufficient sunlight exposure |
Explore related products
What You'll Learn
MS prevalence in Australia is rising
Multiple sclerosis (MS) is a chronic disease that affects the central nervous system, including the brain and spinal cord. It is one of the most common neurological causes of disability in young adults in Australia. The prevalence of MS in Australia has been increasing over the years, with the latest figures showing a significant rise.
In 2021, it was estimated that 131.12 Australians per 100,000 people lived with MS, up from 103.7 per 100,000 in 2017. This equates to approximately 33,000 Australians living with MS in 2021, a notable increase from 25,607 in 2017 and 21,238 in 2010. The rise in MS cases in Australia aligns with global trends, with a person being diagnosed with MS every five minutes worldwide.
There are several factors that may contribute to the increasing prevalence of MS in Australia. One factor is the improvement in detection and diagnosis. MRI scans, for example, are now more readily available, leading to earlier and more accurate diagnoses. Additionally, the average lifespan has increased, providing more opportunities for the disease to develop over time.
While the exact cause of MS is unknown, it is believed to be influenced by a combination of genetic, environmental, and lifestyle factors. Studies have found a correlation between MS prevalence and geographical location, with higher rates observed in areas farther from the equator, such as Tasmania. Other risk factors include a lack of sunlight exposure, adolescent obesity, and certain infectious agents.
The rising number of MS cases in Australia has significant implications for the allocation of resources and the development of treatments. The cost of managing MS has increased substantially, and there is a growing need for specialised healthcare professionals, such as MS nurses, to provide effective care. Furthermore, the increasing prevalence underscores the urgency of investing in research to better understand, treat, and ultimately prevent MS.
Subaru: Australian-Made Cars or Imported?
You may want to see also
Explore related products
MS is more common in southern states
Multiple sclerosis (MS) is a common disease of the central nervous system, affecting the brain, spinal cord, and optic nerve. It is a highly variable condition, with symptoms depending on which areas of the central nervous system are affected. It is a chronic neurological condition that can cause a wide range of symptoms, including fatigue, weakness, numbness, and motor dysfunction. MS is the most common neurological cause of disability in young adults.
In Australia, the number of people living with MS has been increasing over time, with over 33,000 people affected as of 2021. The prevalence of MS is higher in the southern states of Australia compared to the northern regions. Tasmania, a southern state, has seen a very large increase in MS cases between 2017 and 2021. The prevalence of MS in Tasmania is nearly twice as high as in northern regions like Queensland. This trend is also observed globally, with higher rates of MS in regions farther from the equator, including North America, Western Europe, and Australasia.
The reasons for the higher prevalence of MS in southern states and regions farther from the equator are not fully understood, but researchers have proposed several theories. One factor may be the latitude gradient effect, where the prevalence of MS is influenced by a combination of genetic and environmental factors. For example, studies have shown that MS is more prevalent in individuals of northern European ancestry, who may have a higher risk of developing the disease when living in certain geographical areas. Additionally, behavioural and lifestyle risk factors, such as adolescent obesity and insufficient sunlight exposure, can contribute to the development of MS.
The increasing prevalence of MS in Australia and other parts of the world has implications for the resources needed to treat and manage the disease. There is a growing need for investments in research, training for healthcare professionals, and the affordability of treatments and services. While there is currently no known cure for MS, advances in treatment options and early detection methods have helped improve the management of the disease and reduce the severity of symptoms.
Australia's Olympic Host Cities: A Comprehensive Overview
You may want to see also
Explore related products
MS is more common in people of northern European ancestry
Multiple sclerosis (MS) is one of the most common diseases of the central nervous system, affecting the brain, spinal cord, and optic nerve. In Australia, the number of people living with MS has been increasing over the years, with over 33,000 Australians affected as of 2021. The prevalence of MS is higher in the southern states of Australia compared to the northern regions, with Tasmania showing the most startling increase.
MS is known to be more prevalent among people of northern European ancestry, and ancient DNA provides some insights into this phenomenon. Researchers have found that the Yamnaya, a Bronze Age people who migrated into northwestern Europe, carried gene variants that are now associated with an increased risk of developing MS. These genetic variations may have offered protection against infections carried by their cattle and sheep.
The spread of these gene variants can be attributed to the Yamnaya's flourishing and widespread migration throughout the region. This genetic predisposition has persisted through the centuries, resulting in a higher susceptibility to MS among northern Europeans and their descendants. The prevalence of MS in Europe is approximately 142.81 cases per 100,000 people, with Northern Europeans being particularly vulnerable.
The "hygiene hypothesis" offers another perspective on the higher incidence of MS in northern Europeans. This theory suggests that the modern lifestyle, which is often too clean for the immune system to develop adequately, may contribute to the development of allergies and asthma. However, the specific advantage proposed by the papers, enhanced protection against infections, is still a hypothesis.
The increased prevalence of MS in people of northern European ancestry has been a long-standing puzzle in medical science. While the exact causes of MS remain unknown, the combination of genetic and environmental factors is believed to play a significant role in its development. Further research is being conducted to better understand the disease and develop more effective treatments.
Bees in Australia: Population Insights
You may want to see also
Explore related products
MS is treatable, but not curable
Multiple sclerosis (MS) is one of the most common diseases of the central nervous system, affecting the brain, spinal cord, and optic nerve. It is a highly variable condition, impacting each person differently. While there is currently no known cure for MS, it is a treatable condition, and various therapeutic and technological advances are helping people manage their symptoms and live fulfilling and active lives.
The number of people living with MS in Australia has been increasing over the years, with over 33,000 Australians affected as of 2021. The prevalence of MS is higher in the southern states of Australia compared to the northern regions, and Tasmania has seen a particularly sharp rise in cases. The increase in prevalence is attributed to various factors, including early detection, longer lifespans, and risk factors such as insufficient sunlight exposure and adolescent obesity.
MS occurs when the immune system mistakenly attacks the protective covering of nerve fibers, known as myelin, disrupting communication between the brain and the body. This damage to the myelin sheath results in a range of symptoms, including fatigue, weakness, numbness, and motor dysfunction. While there is no single known cause of MS, both genetic and environmental factors contribute to its development. The current hypothesis suggests that individuals with a genetic predisposition may react to certain infectious agents, such as viruses or bacteria.
Although there is no cure for MS, various treatments are available to help manage symptoms and slow down the progression of the disease. These treatments include disease-modifying therapies, medications, and muscle relaxants to reduce relapses and ease symptoms. Corticosteroids, such as methylprednisolone, are also prescribed to suppress the immune system and reduce inflammation during flare-ups. Additionally, advances in treating and understanding MS are made each year, and research progress towards finding a cure is encouraging.
Living with MS can be challenging, both physically and emotionally. Support is crucial for individuals with MS, and various resources are available, including healthcare professionals such as MS nurses, neurologists, physiotherapists, and occupational therapists. Support groups and national charities also provide valuable assistance and connection with others going through similar experiences. Despite the challenges, with early treatment and management, individuals with MS can lead fulfilling lives, and the levels of disability caused by the disease can be significantly reduced.
Grow Big Strawberries: Australia's Ultimate Guide
You may want to see also
Explore related products
MS is a chronic neurological condition
Multiple sclerosis (MS) is a chronic neurological disorder that affects the central nervous system, including the brain and spinal cord. It is one of the most common diseases of the central nervous system, impacting more young people in Australia than any other chronic progressive neurological disease. MS occurs when the immune system mistakenly attacks the protective covering of nerve fibres, known as myelin, which allows electrical impulses to travel quickly and efficiently from the brain to the rest of the body. This disruption can cause a wide range of symptoms, including fatigue, weakness, numbness, and motor dysfunction such as unsteady movements, muscle spasms, and speech difficulties. Eye and vision problems are also common in people with MS, but permanent blindness is rare.
The prevalence of MS in Australia is on the rise, with over 33,000 people living with the condition as of 2021, up from 25,607 in 2017. This increase is attributed to various factors, including early detection, longer lifespans, and risk factors such as insufficient sunlight exposure. The southern states of Australia have a higher prevalence of MS compared to the northern regions, and Tasmania has seen a particularly sharp increase. The increase in prevalence also aligns with worldwide trends, with the highest prevalence found in northern Europe and Canada.
MS affects each person differently, and there is no single pattern to the symptoms. While some individuals may experience mild symptoms with little disability, others may face worsening symptoms and increased disability over time. Relapsing-remitting MS is the most common form, characterised by flare-ups of neurological symptoms followed by periods of recovery or remission. Secondary progressive MS develops in some individuals years or decades after the initial onset of relapsing symptoms, leading to a gradual worsening of symptoms. Primary progressive MS, affecting a minority of those with the disease, is characterised by progressively worsening neurological symptoms from the beginning without periods of recovery.
While there is currently no known cure for MS, various treatments are available to help manage symptoms and slow down the progression of the disease. More than a dozen disease-modifying therapies exist, and technological advances are continuously being made to improve management and understanding of the condition. Advances in detection methods, such as MRI scans, have also contributed to the rising prevalence of MS in Australia.
Chicken Nuggets: Australian Style, What's the Secret?
You may want to see also
Frequently asked questions
Over 33,000 people in Australia are living with multiple sclerosis (MS).
Yes, MS is one of the most common diseases of the central nervous system. It is the most common neurological cause of disability affecting young adults.
MS affects the brain, spinal cord, and optic nerve. Symptoms include fatigue, weakness, numbness, and motor dysfunction, such as unsteady movements, muscle spasms, and speech difficulties.
While there is currently no cure for MS, there are FDA-approved medications that can help to manage symptoms and slow down the progression of the disease.
There is no single cause of MS, but it is believed to be a complex interaction between genetics, environmental factors, and lifestyle factors.
